EchoStar gets another chance to argue that it should not have been held in contempt for allegedly continuing to infringe TiVo's patents.

After two reversals in less than a year, the lawyers in a big-money trade secrets fight between rival hard drive makers Seagate Technology LLC and Western Digital Corp. must be getting positively dizzy by now. And if Western Digital gets its way, the companies' fortunes may take yet another turn.

A federal judge in Spokane took Robbins Geller to task last month over the firm's request for $2.1 million in fees and expenses related to a $7.5 million class action settlement, questioning whether two partners should be sanctioned or referred for disciplinary proceedings for overstating their expenses. The firm apologized Tuesday but defended much of its request.

Allstate's lawyers at Quinn Emanuel ran hard up against federal and state time limits on their claims over more than $700 million in Countrywide residential mortgage-backed securities. But Bank of America and its counsel at Goodwin Procter are still a long way from being clear of the case.

Partner Harold McElhinny is leading the charge for Palo Alto Networks in two suits, including one challenging an established doctrine of patent law.

The Vice-Chancellor, who turns out to be quite a fried chicken connoisseur, split the bird in his ruling, finding that franchisees have the right to amend corporate's advertising proposals. But the corporation hailed Strine's finding that it controls KFC's brand image.

The company has agreed to settle a class action lawsuit brought by investors who accused it of misleading them about the likelihood it would win approval for a potential blockbuster drug to treat obesity.

The deal, negotiated by class counsel at Kessler Topaz and JPMorgan's lawyers at Paul Weiss, resolves ERISA claims by a certified class of pension funds that the bank recklessly invested their securities lending cash collateral in a structured investment vehicle that collapsed in 2008.

Less than two months after Simpson Thacher lost a bid to squash investors' class claims over the antidepressant Pristiq, plaintiffs lawyers at Robbins Geller have reached a $67.5 million settlement with Pfizer to make the case go away.